Clinical Trials Browser

OTHER × ruxolitinib × Thoracic × Clear all

NCT07219576 2026-01-13

PRISM

Phase 1/2 Recruiting

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell

NCT02155465 2019-01-16

Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib

Phase 1/2 Completed

22 enrolled 17 charts

Lung Neoplasms